To use all functions of this page, please activate cookies in your browser.
First diagnostic test for zika virus accepted by WHO
WHO has accepted the first Zika virus Diagnostic test eligible for procurement agencies and Member States. The RealStar® Zika Virus RT-PCR Kit 1.0 manufactured by altona Diagnostics was assessed under the Emergency Use Assessment and Listing Procedure (EUAL) opened to candidate in vitro diagnostics (IVDs) intended for Zika virus diagnosis in February 2016.
A public report with additional details about the WHO Emergency Use Assessment and Listing for RealStar® Zika Virus RT-PCR Kit 1.0. can be obtained via the link on the right side.
The EUAL procedure is an emergency quality assessment mechanism established by WHO during the 2014 Ebola Virus Disease outbreak. It was developed to expedite the availability of IVDs needed in public health emergency situations, based on a minimum set of available quality, safety, and performance data and an agreed plan for further evaluation.
- 1Designer cytokine makes paralyzed mice walk again
- 2New ion trap to create the world's most accurate mass spectrometer
- 3COVID-19 has multiple faces
- 4A prognostic Alzheimer’s disease blood test in the symptom-free stage
- 5Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 6New and highly efficient method for SARS-CoV-2 mutation analysis
- 7Nanocrystals that eradicate bacteria biofilm
- 8Why remdesivir does not fully stop the coronavirus
- 9Detecting COVID-19 antibodies in 10-12 seconds
- 10Single-cell test can reveal precisely how drugs kill cancer cells